a Department of Nephrology , Shandong University Qilu Hospital , Jinan , China.
b Department of Nephrology , Linyi People's Hospital , Linyi , China.
Ren Fail. 2019 Nov;41(1):16-23. doi: 10.1080/0886022X.2019.1568259.
Peritoneal dialysis (PD) related infections, such as peritonitis, are still the main obstacle for the development of PD. Prophylactic antibiotic as one of the interventions to prevent early peritonitis was recommended to use before PD catheter insertion by International Society for Peritoneal Dialysis (ISPD) guidelines, In our hospital, however, since 2012, the prophylactic antibiotics for insertion of PD catheters were not allowed to use because of our hospital's regulation. In order to analyze the outcomes of PD patients without using prophylactic antibiotics before the PD catheter insertion, we compared the PD patients with or without prophylactic antibiotics before PD catheter insertion.
This retrospective study included 247 patients undergoing permanent PD catheter placement with conventional open surgical method consecutively between February 2008 and June 2013. Of these, 154 patients were given intravenous cefazolin, 1.0 g, 0.5-2 h before the procedure (antibiotic group) and 93 patients were not given prophylactic antibiotics (nonantibiotic group). All the patients were administered intermittent PD within 24 h after PD catheter insertion. The early complications and long-term outcomes were recorded respectively.
There was no significant difference in the incidence of peritonitis and exit-site/tunnel infection and mechanical complications between the two groups in the first 30 days after the PD catheter implantation. In addition, after 6 years of follow-up, no difference was seen between the two groups in patient survival, technique survival, and peritonitis-free survival.
Our study does not show any beneficial effect of antibiotic prophylaxis in reducing the postoperative peritonitis.
腹膜透析(PD)相关感染,如腹膜炎,仍然是 PD 发展的主要障碍。国际腹膜透析学会(ISPD)指南建议在 PD 导管插入前使用预防性抗生素作为预防早期腹膜炎的干预措施之一,然而,自 2012 年以来,由于我院的规定,不允许在 PD 导管插入前使用预防性抗生素。为了分析在 PD 导管插入前不使用预防性抗生素的 PD 患者的结果,我们比较了 PD 导管插入前使用或不使用预防性抗生素的 PD 患者。
本回顾性研究纳入了 2008 年 2 月至 2013 年 6 月间连续行常规开放式手术置管的 247 例 PD 患者。其中 154 例患者在置管前 0.5-2 小时内给予静脉头孢唑林,1.0 g(抗生素组),93 例患者未给予预防性抗生素(非抗生素组)。所有患者均在 PD 导管插入后 24 小时内接受间歇性 PD 治疗。分别记录早期并发症和长期结局。
两组患者 PD 导管植入后 30 天内腹膜炎、出口/隧道感染和机械并发症的发生率无显著差异。此外,6 年随访后,两组患者的生存率、技术生存率和无腹膜炎生存率无差异。
本研究并未显示抗生素预防在降低术后腹膜炎方面有任何有益效果。